FI932248A0 - Hepatit B-vaccinkomposition innehaollande ett gallsyrasalt - Google Patents
Hepatit B-vaccinkomposition innehaollande ett gallsyrasaltInfo
- Publication number
- FI932248A0 FI932248A0 FI932248A FI932248A FI932248A0 FI 932248 A0 FI932248 A0 FI 932248A0 FI 932248 A FI932248 A FI 932248A FI 932248 A FI932248 A FI 932248A FI 932248 A0 FI932248 A0 FI 932248A0
- Authority
- FI
- Finland
- Prior art keywords
- gallsyrasalt
- hepatitis
- combination
- vaccine composition
- vaccine
- Prior art date
Links
- SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
- 229940124736 hepatitis-B vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76267891A | 1991-09-18 | 1991-09-18 | |
| PCT/US1992/007982 WO1993005811A1 (en) | 1991-09-18 | 1992-09-18 | A hepatitis b vaccine formulation incorporating a bile acid salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI932248A0 true FI932248A0 (fi) | 1993-05-18 |
| FI932248A FI932248A (fi) | 1993-07-02 |
Family
ID=25065763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI932248A FI932248A (fi) | 1991-09-18 | 1993-05-18 | Hepatit b-vaccinkomposition innehaollande ett gallsyrasalt |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0533492A3 (fi) |
| JP (1) | JPH06503231A (fi) |
| AU (3) | AU657168B2 (fi) |
| CA (1) | CA2096650A1 (fi) |
| FI (1) | FI932248A (fi) |
| WO (1) | WO1993005811A1 (fi) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE168271T1 (de) * | 1992-05-23 | 1998-08-15 | Smithkline Beecham Biolog | Kombinierte impfstoffe, die hepatitis b oberfläche antigen und andere antigenen enthalten |
| GB9305599D0 (en) * | 1993-03-18 | 1993-05-05 | Unilever Plc | Detergent compositions |
| CZ104397A3 (cs) * | 1994-10-05 | 1998-06-17 | Antex Biologics Inc. | Způsob pěstování střevních bakterií se zvýšenými antigenními vlastnostmi a vakcina s obsahem těchto bakterií |
| DK0911416T3 (da) | 1997-10-01 | 2006-08-14 | Dsm Ip Assets Bv | Fremgangsmåde til fremstilling af protein |
| FR2803599B1 (fr) * | 2000-01-06 | 2004-11-19 | Inst Nat Sante Rech Med | Nouveau virus mute de l'hepatite b, ses constituants nucleiques et proteiques et leurs applications |
| UA79735C2 (uk) | 2000-08-10 | 2007-07-25 | Глаксосмітклайн Байолоджікалз С.А. | Очищення антигенів вірусу гепатиту b (hbv) для використання у вакцинах |
| KR100518276B1 (ko) * | 2002-12-18 | 2005-09-29 | 김기영 | 동물의 담즙을 이용한 새로운 안과용 조성물 |
| CA2529997A1 (en) | 2003-06-20 | 2004-12-29 | Dade Behring Marburg Gmbh | Novel surface protein (hbsag) variant of hepatitis b virus |
| ES2385481T3 (es) * | 2003-06-20 | 2012-07-25 | Siemens Healthcare Diagnostics Products Gmbh | Nueva variante de proteína de superficie (HbsAg) del virus de hepatitis B |
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| US20080044438A1 (en) * | 2006-03-17 | 2008-02-21 | Ostroff Gary R | Yeast Cell Particles As Oral Delivery Vehicles For Antigens |
| JP5676452B2 (ja) * | 2008-09-29 | 2015-02-25 | カディラ ファーマシューティカルズ リミテッド | ワクチンアジュバント |
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| EP2675460A4 (en) | 2011-02-18 | 2014-07-09 | Kythera Biopharmaceuticals Inc | TREATMENT OF FAT TISSUE UNDER CHIN |
| US8653058B2 (en) | 2011-04-05 | 2014-02-18 | Kythera Biopharmaceuticals, Inc. | Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits |
| UY34506A (es) * | 2012-12-10 | 2014-06-30 | Fernando Amaury Ferreira Chiesa | Adyuvante de vacunación, preparación y vacunas que lo contienen |
| WO2018165766A1 (en) * | 2017-03-16 | 2018-09-20 | Therapure Biopharma Inc. | Method for purification of albumin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA792485B (en) * | 1978-06-07 | 1980-06-25 | New York Blood Center Inc | Vaccine for active immunization containing hepatitis b surface and/or e-antigens |
| JPS5610119A (en) * | 1979-07-05 | 1981-02-02 | Alpha Therapeutic Corp | Manufacture of b type hepatitis infection preventive vaccine |
| US4977092A (en) * | 1985-06-26 | 1990-12-11 | Amgen | Expression of exogenous polypeptides and polypeptide products including hepatitis B surface antigen in yeast cells |
| JPS60197629A (ja) * | 1984-03-16 | 1985-10-07 | Chemo Sero Therapeut Res Inst | ＨＢｓ抗原の精製方法 |
| JPS60196185A (ja) * | 1984-03-19 | 1985-10-04 | Chemo Sero Therapeut Res Inst | 形質転換酵母の培養方法 |
| US4649192A (en) * | 1985-05-30 | 1987-03-10 | Smith Kline-Rit | Method for the isolation and purification of hepatitis B surface antigen using polysorbate |
| JPS632932A (ja) * | 1986-06-23 | 1988-01-07 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| ZA868611B (en) * | 1986-11-13 | 1987-07-29 | Amgen | Fermentation methods for hepatitis vaccine production |
| GB8919819D0 (en) * | 1989-09-01 | 1989-10-18 | Coopers Animal Health | Complexes having adjuvant activity |
| JP2841229B2 (ja) * | 1990-04-19 | 1998-12-24 | ライオン株式会社 | う蝕ワクチン組成物 |
| DZ1706A1 (fr) * | 1992-08-07 | 2002-02-17 | Merck & Co Inc | Vaccin contre le virus de l'hepatite a. |
-
1992
- 1992-09-18 AU AU26703/92A patent/AU657168B2/en not_active Ceased
- 1992-09-18 WO PCT/US1992/007982 patent/WO1993005811A1/en active Application Filing
- 1992-09-18 JP JP5506291A patent/JPH06503231A/ja active Pending
- 1992-09-18 CA CA 2096650 patent/CA2096650A1/en not_active Abandoned
- 1992-09-18 EP EP19920308534 patent/EP0533492A3/en not_active Withdrawn
-
1993
- 1993-05-18 FI FI932248A patent/FI932248A/fi not_active Application Discontinuation
-
1995
- 1995-02-15 AU AU12283/95A patent/AU1228395A/en not_active Abandoned
- 1995-02-15 AU AU12282/95A patent/AU1228295A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0533492A3 (en) | 1994-08-10 |
| JPH06503231A (ja) | 1994-04-14 |
| AU1228395A (en) | 1995-04-13 |
| WO1993005811A1 (en) | 1993-04-01 |
| CA2096650A1 (en) | 1993-03-21 |
| AU1228295A (en) | 1995-04-13 |
| AU657168B2 (en) | 1995-03-02 |
| FI932248A (fi) | 1993-07-02 |
| AU2670392A (en) | 1993-04-27 |
| EP0533492A2 (en) | 1993-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI932248A0 (fi) | Hepatit B-vaccinkomposition innehaollande ett gallsyrasalt | |
| DK0479695T3 (da) | Flaske med bred fodstilling | |
| FI925381A0 (fi) | Signaleringsanordningar i ett centralsystem foer cellulaer mobiltelefoni | |
| FI923969A (fi) | Adaptiv foerdelning av resurser i ett mobiltelefonsystem | |
| NO932575D0 (no) | Skikonstruksjon med skallformet overdel i ett stykke | |
| DK0512017T3 (da) | Vacciner | |
| FI933549A (fi) | Lyssnande kontrollkanal i ett cellulaert mobilradiotelefonsystem | |
| DE69211546D1 (de) | Monatsbinde mit laschen | |
| FI924646A (fi) | Oeverspaennings- och oeverstroemmsskydd foer ett linjeoeverdrag | |
| FI921367A (fi) | Ytbelagd tuggummiprodukt med en underbelaeggning av ett emulgermedel | |
| DE69131394T2 (de) | Maschinenlesbares Zeichen mit Mehrfachauflösung | |
| DE69120171T2 (de) | Härtbare Zusammensetzung | |
| DE69207501D1 (de) | Giessformzusammensetzung | |
| DE69113103T2 (de) | Trümmerfestes Kernbrennstabbündelfussstück. | |
| FI921361A (fi) | Lagerhus foer ett flerradigt rullager | |
| FI924335A0 (fi) | Injekterbara kompositioner med foerdroejd verkan och foerfaranden. | |
| DE69120852T2 (de) | Methacrylharzzusammensetzung | |
| FI925247A0 (fi) | Distansorgansystem foer ett transparent isoleringssystem | |
| NO922649L (no) | Flat formdel utformet i ett stykke | |
| FI924361A (fi) | Identifikationsbaermedel foer ett tillslutningssystem | |
| NO921807L (no) | Brennstoffsammensetning | |
| DE69119398T2 (de) | Kontrollwaagen mit Längenberücksichtigung | |
| ITMI911812A1 (it) | Benzofenoni ad azione antifungina | |
| DE69225266T2 (de) | Bis-bibenzimidazol Zusammensetzung | |
| DE69222990T2 (de) | Harzzusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application lapsed |